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Anti-N-methyl-D-aspartate receptor encephalitis is a neurological, autoimmune disorder tightly conceptualized only as recently
as the mid-2000s. It presents itself in a combination of psychiatric, neurological, and autonomic features. We observe a unique
case with probable earlier episode (prior to the mid-2000s conceptualization of the disease) and a later relapse, accompanying a
comprehensive neuropsychological profile tracked after the relapse and subsequent improvement. Neurocognitive findings revealed
residual frontal deficits with mood changes even in the state after plasmapheresis. This case is the first to describe posttreatment
cognition in anti-NMDAR encephalitis after probable serial autoimmune episodes.

1. Introduction
Anti-N-methyl-D-aspartate receptor (anti-NMDAR) encephalitis is a neurological, autoimmune disorder that presents
itself in a combination of psychiatric, neurological, and
autonomic features. Typical representations include generally
acute personality and behavioral changes, memory loss,
hallucinations, dyskinesia, dystonia, and seizures. Significant
portions of the patients, up to 80%, are women with a median
age in the early twenties, and ovarian teratomas and related
autoimmune processes are found in approximately half of
the cases [1–5]. In this case report, we present a patient with
two paroxysms of anti-NMDAR encephalitis accompanied by
limited cognitive abilities, frontal deficits, and mood changes.

2. Case Presentation
The patient is a 33-year-old married woman. She managed
the financial aspects and business ventures of the three
companies that she and her husband own. Her social history
was reported normal with no incidents of significant trauma

or substance abuse. Developmental history is unremarkable,
and she completed one and a half years of college. The family
history showed bipolar disorder in one sibling, hypertension,
diabetes, and a strong presence of depression.
Upon records review, documentation revealed that the
patient possibly, or rather probably, experienced her first
episode of autoimmune encephalitis at the age of 24, which
occurred prior to the first conceptualization documented by
Dalmau et al. [3]. This episode was paired with headaches,
hallucinations, delusions, violent outbursts, seizures, and
then a two-month long coma. During this time, hallucinations included seeing a television on the ceiling. She was
hospitalized at an inpatient psychiatric facility, but details of
her clinical diagnoses at the time remain unclear. She then
recovered drastically after receiving a high dose of prednisone and only reported mild to moderate residual deficits.
While no formal neuropsychological measures were given
at the time per report, residual deficits included low-level
math computation, slowed processing speed, and short-term
memory deficits, enough to a level that required supervision
over daily living activities. This continued to resolve for about
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Table 1: Neuropsychological test scores.
Function

Measure∗

Standard scores

Percentile

Estimated premorbid IQ

WRAT-4 Reading subtest

86

18

Full scale IQ

WAIS- IV

75

5

Verbal memory

Total verbal learning
New learning as distraction to old learning
Short delay recall
Long delay recall
Recognition

CVLT-II trials 1–5 total
CVLT-II trial B
CVLT-II short delay
CVLT-II long delay
CVLT-II discriminability

98
107
78
85
115

45
68
7
16
84

Visual memory

Total visual learning
Delay recall
Recognition

BVMT-R trials 1–3 total
BVMT-R delay
BVMT-R Discrimination Index

<65
<65
—

<1
<1
1-2

Working memory
Psychomotor speed & attention

WAIS-IV Working Memory Index
Trails A

80
88

9
21

Mental flexibility
Response inhibition

Trails B
Stroop C-W
WCST total error
WCST-64 perseverative responses
WCST-64 perseverative errors
WCST-64 categories completed
WCST-64 failure to maintain set

58
91
78
86
87
—
—

.3
27
7
18
9
2–5
—

WAIS-IV Processing Speed Index
Stroop W
Stroop C

86
84
86

18
14
16

Verbal comprehension

WAIS-IV Verbal Comprehension Index

83

13

Semantic fluency
Phonemic fluency
Naming
Repetition

Animals
FAS
BNT-2
MAE sentences

58
58
64
71

.3
.3
.8
3

Comprehension

MAE token

106

67

Perceptual reasoning

WAIS-IV Perceptual Reasoning Index

71

3

Visuomotor construction

Clock drawing

—

—

Visual perception

JOLO

79

8

Manual dexterity

GD dominant hand
GD nondominant hand

67
64

1.4
.8

Domain
Expected
intelligence
General
intelligence

Attention

Higher order
executive skills

Novel problem solving

Processing speed
Speed
Verbal general

Expressive

Receptive
General
perception
Visuospatial
construction
Spatial
perception
Motor

Recognition speed

∗

WRAT-4 Reading = Wide Range Achievement Test, 4th Edition; WAIS-IV = Wechsler Adult Intelligence Scale, 4th Edition; CVLT-II = California Verbal
Learning Test, 2nd Edition; BVMT-R = Brief Visuospatial Memory Test-Revised; Trails A = Trail Making Test Form A; Trails B = Trail Making Test Form B;
Stroop C = Stroop Color Subtest; Stroop W = Stroop Word Subtest; Stroop C-W = Stroop Color-Word Subtest; WCST = Wisconsin Card Sorting Test; Animals =
semantic fluency; FAS = phonemic fluency; BNT-2 = Boston Naming Test, 2nd Edition; MAE = Multilingual Aphasia Examination; JOLO = Judgment of Line
Orientation Test; GD = grip dynamometer.

2 years until she was able to drive and care for her children
independently. However, she remained agitated and irritable
compared to her baseline.
The second episode occurred nine years later and was
much more severe. It involved personality changes, perseveration in behaviors and speech, impulsive financial behaviors

(e.g., spending over $10,000 on clothes in one week), paranoia, psychosis, and aggressive outbursts. She also had dressing apraxia, and her psychosis included visual hallucinations
of monsters and demons, melting ceilings, delusions of her
children being trapped under the bathroom tiles, and the
belief that she had to free them using only her fingernails. She
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was under restraint during her inpatient stay for a week due to
aggressive outbursts. She also developed status epilepticus 4
times, which were treated with conventional IV antiepileptic
drugs.
Video EEG showed epileptic activity in the right frontoparietal region. The remainder of the workup was negative,
including MRI, CT, PET, transvaginal US, and LP. MRIs of the
brain and pelvis were both negative (pelvic MRI was initiated
to rule out ovarian teratoma). CSF was unrevealing including
T. pallidum, West Nile, IgG, albumin, cell ct/protein/glucose,
cultures, cryptococcal Ag, India ink, HSV PCR, and TB.
Laboratory testing by Mayo Clinic revealed that the serum
anti-NMDA antibodies were negative, but CSF anti-NMDA
antibodies with repeat testing were found to be positive.
Treatment included bilateral salpingo-oophorectomy (but
no ovarian teratoma was found), IVIG transfusion, and
plasmapheresis. She was later switched to rituximab infusion
and also received medications for psychosis and seizures.
Final diagnosis was documented as anti-NMDA-receptor
encephalitis without teratoma. A neuropsychological evaluation occurred after treatment. It showed numerous cognitive
deficits such as impairments in visual memory, mental
flexibility, expressive language, visuospatial skills, and motor
dexterity (see Table 1). The most significant problems were
present in verbal fluency (semantic and phonemic fluency,
both <1st percentile), mental flexibility (<1st percentile),
and elevated depression and anxiety. She continues to have
compromised cognitive status along with residual frontal
deficits and mood changes. She and her guardian provided
consent for this case study to be published.

3. Discussion
In anti-NMDAR encephalitis, antibodies are directed
towards the NR1 subunit of the NMDA receptor causing a
depletion of NMDA receptors [1, 4, 6, 7]. The lack of receptors
causes neuropsychiatric symptoms, attributable to ovarian
teratomas and autoimmune processes in approximately half
of the cases [2–4, 6, 8]. Recognizing the symptom complex
is crucial to diagnosis [7]. Commonly, patients develop a
multistage illness that progresses from psychiatric symptoms
to more extreme global symptoms [1]. Up to half of the
women diagnosed with anti-NMDAR encephalitis have an
underlying ovarian teratoma [3, 8].
Treatment involves immunosuppression with steroids
and intravenous administration [1, 4, 7, 9]. Many patients
recover well after appropriate treatment [10]. While it is
thought that there is a higher prevalence of anti-NMDAR
encephalitis, data on posttreatment cognitive states remain
rather limited [11, 12]. This case revealed residual frontal
deficits with mood changes in the context of anti-NMDAR
encephalitis. This case is the first to describe posttreatment
cognition in anti-NMDAR encephalitis after probable serial
autoimmune episodes.

4. Conclusion
Anti-N-methyl-D-aspartate receptor encephalitis is a neurological, autoimmune disorder tightly conceptualized only as
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recently as the mid-2000s. It presents itself in a combination
of psychiatric, neurological, and autonomic features. This
case was a unique case with probable earlier episode (prior to
the mid-2000s operationalization of the disease) and a later
relapse, accompanying a comprehensive neuropsychological
profile tracked after the relapse and subsequent improvement.
Neurocognitive findings revealed residual frontal deficits
with mood changes even in the state after plasmapheresis,
and these deficits do not appear to associate neatly with
structural brain damage visible in imaging (or lack thereof),
as clinical symptoms were likely the sequelae of a more global
neuroinflammatory damage that occurred. This case is the
first to describe posttreatment cognition in anti-NMDAR
encephalitis after probable serial autoimmune episodes.
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